Lestaurtinib
File:Lestaurtinib.png | |
Identifiers | |
---|---|
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C26H21N3O4 |
Molar mass | 439.462 g/mol |
WikiDoc Resources for Lestaurtinib |
Articles |
---|
Most recent articles on Lestaurtinib Most cited articles on Lestaurtinib |
Media |
Powerpoint slides on Lestaurtinib |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Lestaurtinib at Clinical Trials.gov Clinical Trials on Lestaurtinib at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Lestaurtinib
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Lestaurtinib Discussion groups on Lestaurtinib Patient Handouts on Lestaurtinib Directions to Hospitals Treating Lestaurtinib Risk calculators and risk factors for Lestaurtinib
|
Healthcare Provider Resources |
Causes & Risk Factors for Lestaurtinib |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Lestaurtinib (rINN, codenamed CEP-701) is a tyrosine kinase inhibitor undergoing research for the treatment of acute myelogenous leukemia (AML) and myeloproliferative disorders. It is an analog of staurosporine.
As of 2008, it is currently in Phase III clinical trials for AML and Phase II clinical trials for myeloproliferative disorders. [1]
It is being developed by Cephalon.
References
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Tyrosine kinase inhibitors